Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study
JMIR Neurotechnology · 2023
DOI: 10.2196/41439 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift JMIR Neurotechnology, 2023. Verfasst von Jacob A Andrews und 26 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health and Care Research MindTech MedTech Co-operative University of Nottingham Nottingham United Kingdom. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Background
Multiple sclerosis (MS), epilepsy, and depression are chronic central nervous system conditions in which remote measurement technology (RMT) may offer benefits compared with usual assessment. We previously worked with clinicians, patients, and researchers to develop 13 use cases for RMT: 5 in epilepsy (seizure alert, seizure counting, risk scoring, triage support, and trend analysis), 3 in MS (detecting silent progression, detecting depression in MS, and donating data to a biobank), and 5 in depression (detecting trends, reviewing treatment, self-management, comorbid monitoring, and carer alert).
Objective
In this study, we aimed to evaluate the use cases and related implementation issues with an expert panel of clinicians external to our project consortium.
Methods
We used a Delphi exercise to validate the use cases and suggest a prioritization among them and to ascertain the importance of a variety of implementation issues related to RMT. The expert panel included clinicians from across Europe who were external to the project consortium. The study had 2 survey rounds (n=23 and n=17) and a follow-up interview round (n=9). Data were analyzed for consensus between participants and for stability between survey rounds. The interviews explored the reasons for answers given in the survey.
Results
The findings showed high stability between rounds on questions related to specific use cases but lower stability on questions relating to wider issues around the implementation of RMT. Overall, questions on wider issues also had less consensus. All 5 use cases for epilepsy (seizure alert, seizure counting, risk scoring, triage support, and trend analysis) were considered beneficial, with consensus among participants above the a priori threshold for most questions, although use case 3 (risk scoring) was considered less likely to facilitate or catalyze care. There was very little consensus on the benefits of the use cases in MS, although this may have resulted from a higher dropout rate of MS clinicians (50%). Participants agreed that there would be benefits for all 5 of the depression use cases, although fewer questions on use case 4 (triage support) reached consensus agreement than for depression use cases 1 (detecting trends), 2 (reviewing treatment), 3 (self-management), and 5 (carer alert). The qualitative analysis revealed further insights into each use case and generated 8 themes on practical issues related to implementation.
Conclusions
Overall, these findings inform the prioritization of use cases for RMT that could be developed in future work, which may include clinical trials, cost-effectiveness studies, and the commercial development of RMT products and services. Priorities for further development include the use of RMT to provide more accurate records of symptoms and treatment response than is currently possible and to provide data that could help inform patient triage and generate timely alerts for patients and carers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Health and Care Research MindTech MedTech Co-operative University of Nottingham Nottingham United Kingdom.
- Academic Unit of Mental Health and Clinical Neurosciences School of Medicine University of Nottingham Nottingham United Kingdom.
- Human Factors Research Group Faculty of Engineering University of Nottingham Nottingham United Kingdom.
- National Institute for Health and Care Research Applied Research Collaboration East Midlands School of Medicine University of Nottingham Nottingham United Kingdom.
- Patient Advisory Board RADAR-CNS Kings College London London United Kingdom.
- Freiburg Epilepsy Center, Medical Center Faculty of Medicine University of Freiburg Freiburg Germany.
ORCID-Profile: Jacob A Andrews, Michael P Craven, Boliang Guo, Janice Weyer, Simon Lees, Spyridon I Zormpas, Sarah E Thorpe, Julie Devonshire, Victoria San Antonio-Arce, William P Whitehouse, Jessica Julie, Sam Malins, Alexander Hammers, Andreas Reif, Henricus G Ruhe, Federico Durbano, Stefano Barlati, Arjune Sen, Jette L Frederiksen, Alessandra Martinelli, Antonio Callen, Joan Torras-Borrell, Nuria Berrocal-Izquierdo, Ana Zabalza, Richard Morriss, Chris Hollis
Zitieren
APA
Andrews, J. A., Craven, M. P., Guo, B., Weyer, J., Lees, S., Zormpas, S. I., Thorpe, S. E., Devonshire, J., San Antonio-Arce, V., Whitehouse, W. P., Julie, J., Malins, S., Hammers, A., Reif, A., Ruhe, H. G., Durbano, F., Barlati, S., Sen, A., Frederiksen, J. L., …, & RADAR-CNS Consortium (2023). Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study. JMIR Neurotechnology. https://doi.org/10.2196/41439
Vancouver
Andrews JA, Craven MP, Guo B, Weyer J, Lees S, Zormpas SI, et al. Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study. JMIR Neurotechnology. 2023. doi:10.2196/41439
BibTeX
@article{Andrews2023,
author = {Andrews, Jacob A and Craven, Michael P and Guo, Boliang and Weyer, Janice and Lees, Simon and Zormpas, Spyridon I and Thorpe, Sarah E and Devonshire, Julie and San Antonio-Arce, Victoria and Whitehouse, William P and Julie, Jessica and Malins, Sam and Hammers, Alexander and Reif, Andreas and Ruhe, Henricus G and Durbano, Federico and Barlati, Stefano and Sen, Arjune and Frederiksen, Jette L and Martinelli, Alessandra and Callen, Antonio and Torras-Borrell, Joan and Berrocal-Izquierdo, Nuria and Zabalza, Ana and Morriss, Richard and Hollis, Chris and RADAR-CNS Consortium, RADAR-CNS Consortium},
title = {Clinical Perspectives on Using Remote Measurement Technology in Assessing Epilepsy, Multiple Sclerosis, and Depression: Delphi Study},
journal = {JMIR Neurotechnology},
year = {2023},
doi = {10.2196/41439}
}
EUVIMED